PPARG and cancer: The recent discovery that the small molecule PPARγ inhibitor compounds reduce tubulin protein levels, withoutaffecting in vitro polymerization rates, suggests the exciting possibility that targeting tubulin levelsdirectly, rather than microtubule dynamics, might be an additional way tomanipulate microtubule biology to kill cancer cells.